Cite
HARVARD Citation
Pignolet, B. et al. (2016). CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy. Neurology. pp. 2491-2494. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pignolet, B. et al. (2016). CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy. Neurology. pp. 2491-2494. [Online].